Further studies confirmed that overexpression of circFAM169A can also inhibit the proliferation and cell viability of ovarian cancer through CCK-8 and EdU assay, and inhibition of RPS6KA2 can partially counteract the effects of circFAM169A (Figures 6G, H). This evidence concerns the gene RPS6KA2 and ovarian carcinoma.